141 related articles for article (PubMed ID: 9478296)
1. Direct intraperitoneal insemination in ovarian hyperstimulation cycles induced with gonadotropin-releasing hormone agonist.
Misao R; Itoh M; Nakanishi Y; Tamaya T
Clin Exp Obstet Gynecol; 1997; 24(3):133-4. PubMed ID: 9478296
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
[TBL] [Abstract][Full Text] [Related]
3. Direct intraperitoneal insemination compared to intrauterine insemination in superovulated cycles: a randomized cross-over study.
Tiemessen CH; Bots RS; Peeters MF; Evers JL
Gynecol Obstet Invest; 1997; 44(3):149-52. PubMed ID: 9359638
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
Aboulghar MA; Mansour RT; Serour GI
Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
[TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose.
Ponzano A; Colangelo EC; Di Biase L; Romani F; Tiboni GM
Gynecol Endocrinol; 2017 Mar; 33(3):208-211. PubMed ID: 27922279
[TBL] [Abstract][Full Text] [Related]
7. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
8. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome.
Christopoulos G; Vlismas A; Carby A; Lavery S; Trew G
Hum Fertil (Camb); 2016 Sep; 19(3):199-206. PubMed ID: 27662416
[TBL] [Abstract][Full Text] [Related]
9. [The influence of FSH stimulation on the results of intrauterine insemination].
Jedrzejczak P; Pawelczyk L
Ginekol Pol; 1998 Jun; 69(6):425-9. PubMed ID: 9695356
[TBL] [Abstract][Full Text] [Related]
10. The initial flare-up induced by gonadotropin releasing hormone agonist may serve as a predictor of ovarian response in the current IVF-ET treatment cycle in normogonadotropic women aged 40-48 years.
Avrech OM; Royburt M; Sabah G; Zukerman Z; Pinkas H; Amit S; Ovadia J; Fisch B
J Assist Reprod Genet; 1996 May; 13(5):395-400. PubMed ID: 8739055
[TBL] [Abstract][Full Text] [Related]
11. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A
J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044
[TBL] [Abstract][Full Text] [Related]
12. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
Lindner C; Braendle W; Köhler S; Bettendorf G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
[TBL] [Abstract][Full Text] [Related]
13. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
14. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
[TBL] [Abstract][Full Text] [Related]
15. Direct intraperitoneal insemination and controlled ovarian hyperstimulation in subfertile couples.
Ben Rhouma K; Ben Miled E; Ben Marzouk A; Rihani M; Bakir M
J Assist Reprod Genet; 1994 Apr; 11(4):189-92. PubMed ID: 7711381
[TBL] [Abstract][Full Text] [Related]
16. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
Arcaini L; Bianchi S; Baglioni A; Marchini M; Tozzi L; Fedele L
J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
[TBL] [Abstract][Full Text] [Related]
17. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
[TBL] [Abstract][Full Text] [Related]
19. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
[TBL] [Abstract][Full Text] [Related]
20. Rescue hCG to treat empty follicle syndrome after the use of a GnRH agonist as oocyte maturation trigger: First report on fresh embryo transfer and clinical pregnancy.
Christopoulos G; Vlismas A; Barsoum-Derias E; El-Shawarby S; Trew G; Lavery S
Hum Fertil (Camb); 2015; 18(4):248-52. PubMed ID: 26400626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
